102 related articles for article (PubMed ID: 18681861)
21. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
22. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation.
Hansenne I; Louis C; Martens H; Dorban G; Charlet-Renard C; Peterson P; Geenen V
Neuroimmunomodulation; 2009 Jan; 16(1):35-44. PubMed ID: 19077444
[TBL] [Abstract][Full Text] [Related]
23. Quantification and molecular characterization of regulatory T cells in connective tissue diseases.
Banica L; Besliu A; Pistol G; Stavaru C; Ionescu R; Forsea AM; Tanaseanu C; Dumitrache S; Otelea D; Tamsulea I; Tanaseanu S; Chitonu C; Paraschiv S; Balteanu M; Stefanescu M; Matache C
Autoimmunity; 2009 Jan; 42(1):41-9. PubMed ID: 18800250
[TBL] [Abstract][Full Text] [Related]
24. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
25. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
[TBL] [Abstract][Full Text] [Related]
26. Neuropilin-1 is not a marker of human Foxp3+ Treg.
Milpied P; Renand A; Bruneau J; Mendes-da-Cruz DA; Jacquelin S; Asnafi V; Rubio MT; MacIntyre E; Lepelletier Y; Hermine O
Eur J Immunol; 2009 Jun; 39(6):1466-71. PubMed ID: 19499532
[TBL] [Abstract][Full Text] [Related]
27. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
[TBL] [Abstract][Full Text] [Related]
28. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
29. Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.
Matsumoto K; Inoue H; Fukuyama S; Kan-O K; Eguchi-Tsuda M; Matsumoto T; Moriwaki A; Nakano T; Nakanishi Y
Respirology; 2009 Mar; 14(2):187-94. PubMed ID: 19192224
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the 'no eosinophils' rule: are eosinophils truly absent in pityriasis lichenoides, connective tissue disease, and graft-vs.-host disease?
Sharon VR; Konia TH; Barr KL; Fung MA
J Cutan Pathol; 2012 Apr; 39(4):413-8. PubMed ID: 22443393
[TBL] [Abstract][Full Text] [Related]
31. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
32. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Jin J; Li XY; Zhou le D; Huo Z; Zhou JH; Chen W
Digestion; 2009; 79(3):169-76. PubMed ID: 19329856
[TBL] [Abstract][Full Text] [Related]
34. Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.
Bruinsma M; van Soest PL; Leenen PJ; Löwenberg B; Cornelissen JJ; Braakman E
J Immunol; 2009 Jun; 182(12):7364-9. PubMed ID: 19494258
[TBL] [Abstract][Full Text] [Related]
35. The use of synchrotron infrared microspectroscopy in the assessment of cutaneous T-cell lymphoma vs. pityriasis lichenoides chronica.
El Bedewi A; El Anany G; El Mofty M; Kretlow A; Park S; Miller LM
Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):93-7. PubMed ID: 20415741
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of FOXP3.
Buckner JH; Ziegler SF
Ann N Y Acad Sci; 2008 Nov; 1143():151-69. PubMed ID: 19076349
[TBL] [Abstract][Full Text] [Related]
37. The utility of the in situ detection of T-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates.
Magro CM; Nuovo GJ; Crowson AN
Diagn Mol Pathol; 2003 Sep; 12(3):133-41. PubMed ID: 12960695
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
39. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3.
Allan SE; Song-Zhao GX; Abraham T; McMurchy AN; Levings MK
Eur J Immunol; 2008 Dec; 38(12):3282-9. PubMed ID: 19039775
[TBL] [Abstract][Full Text] [Related]
40. Recent thymic origin, differentiation, and turnover of regulatory T cells.
Mabarrack NH; Turner NL; Mayrhofer G
J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
